EUVIMEDEUVIMED entdecken
Open Access

Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation

Linfeng Zheng, Wenjuan Mei, Jing Zhou, Xin Wei, Zhijuan Huang, Xiaozhen Lin, Li Zhang, Wei Liu, Qian Wu, Jinhong Li, Yan Yan

Experimental and Therapeutic Medicine · 15.02.2024 · 27 (4)

DOI: 10.3892/etm.2024.12430 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Experimental and Therapeutic Medicine, online erschienen am 15.02.2024. Verfasst von Linfeng Zheng und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, P.R. China. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

antifibrotic therapyfluorofenidoneinflammationlysosomal cathepsinrenal fibrosis

Autor:innen und Institutionen

  • Department of Nephrology, The First Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi 330006, P.R. China.

Zitieren

APA

Zheng, L., Mei, W., Zhou, J., Wei, X., Huang, Z., Lin, X., Zhang, L., Liu, W., Wu, Q., Li, J., & Yan, Y. (2024). Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation. Experimental and Therapeutic Medicine, 27(4). https://doi.org/10.3892/etm.2024.12430

Vancouver

Zheng L, Mei W, Zhou J, Wei X, Huang Z, Lin X, et al. Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation. Experimental and Therapeutic Medicine. 2024;27(4). doi:10.3892/etm.2024.12430

BibTeX
@article{Zheng2024,
  author = {Zheng, Linfeng and Mei, Wenjuan and Zhou, Jing and Wei, Xin and Huang, Zhijuan and Lin, Xiaozhen and Zhang, Li and Liu, Wei and Wu, Qian and Li, Jinhong and Yan, Yan},
  title = {Fluorofenidone attenuates renal fibrosis by inhibiting lysosomal cathepsin‑mediated NLRP3 inflammasome activation},
  journal = {Experimental and Therapeutic Medicine},
  year = {2024},
  volume = {27},
  number = {4},
  doi = {10.3892/etm.2024.12430}
}
Kostenlos starten →